Clinical significance of isolation of Mycobacterium avium complex from respiratory specimens

Journal of the Formosan Medical Association

Volumn 109, Issue 7, 2010, Pages 517-523

  Shen, Meng Chuan ^a   Lee, Susan Shin Jung ^b   Huang, Tsi Shu ^b   Liu, Yung Ching ^c  

^a PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antibiotic susceptibility testings; Computed tomography; Mycobacterium avium complex; Nontuberculous mycobacteria; Pulmonary infection

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; MINOCYCLINE; PYRAZINAMIDE; RIFAMPICIN; ANTIINFECTIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD SAMPLING; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; FEMALE; HUMAN; LUNG INFECTION; LUNG TUBERCULOSIS; MALE; MEDICAL RECORD REVIEW; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; PROGNOSIS; ATYPICAL MYCOBACTERIOSIS; DRUG EFFECT; FOLLOW UP; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; RADIOGRAPHY; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SPUTUM; TAIWAN; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SPUTUM; TAIWAN; TREATMENT OUTCOME;

EID: 77955493457     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(10)60086-1     Document Type: Article

References (22)

1. Kasperbauer SH, Daley CL Diagnosis and treatment of infections due to Mycobacterium avium complex. Semin Respir Crit Care Med 2008, 29:569-576.
2. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
3. Wong KS, Lin TY, Huang YC, et al. Nontuberculous my-cobacterial pulmonary disease in an immunocompetent adolescent. Respir Care 2008, 53:908-911.
4. Ye JJ, Wu TS, Chiang PC, et al. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease. J Microbiol Immunol Infect 2007, 40:342-348.
5. Ding LW, Lai CC, Lee LN, et al. Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997-2003. Epidemiol Infect 2006, 134:1060-1067.
6. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. Approved Standard. Wayne, PA: NCCLS; 2003. Document No. M24-T2.
7. Heifets L Susceptibility testing of Mycobacterium avium complex isolates. Antimicrob Agents Chemother 1996, 40:1759-1767.
8. Glassroth J Pulmonary disease due to nontuberculous my-cobacteria. Chest 2008, 133:243-251.
9. Ramirez J, Mason C, Ali J, et al. Mycobacterium avium complex pulmonary disease: management options in HIVnegative patients. J La State Med Soc 2008, 160:248-254. quiz 254, 293.
10. Maugein J, Dailloux M, Carbonnelle B, et al. Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease. Eur Respir J 2005, 26:1092-1096.
11. Choudhri S, Manfreda J, Wolfe J, et al. Clinical significance of nontuberculous mycobacteria isolates in a Canadian tertiary care center. Clin Infect Dis 1995, 21:128-133.
12. Martin DS, Oray-Schrom P, Amoateng-Adjepong Y Emerging significance of Mycobacterium avium-complex infection in an inner-city hospital. Conn Med 2002, 66:323-330.
13. Wittram C, Weisbrod GL Mycobacterium avium complex lung disease in immunocompetent patients: radiography-CT correlation. Br J Radiol 2002, 75:340-344.
14. Tanaka E, Amitani R, Niimi A, et al. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997, 155:2041-2046.
15. Kubo K, Yamazaki Y, Hachiya T, et al. Mycobacterium avium-intracellulare pulmonary infection in patients without known predisposing lung disease. Lung 1998, 176:381-391.
16. Okumura M, Iwai K, Ogata H, et al. Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 2008, 47:1465-1472.
17. Corti M, Palmero D Mycobacterium avium complex infection in HIV/AIDS patients. Expert Rev Anti Infect Ther 2008, 6:351-363.
18. Roos F, Flepp M, Figueras G, et al. Clinical manifestations and predictors of survival in AIDS patients with disseminated Mycobacterium avium infection. Eur J Clin Microbiol Infect Dis 2001, 20:428-430.
19. Raju B, Schluger NW Significance of respiratory isolates of Mycobacterium avium complex in HIV-positive and HIVnegative patients. Int J Infect Dis 2000, 4:134-139.
20. El-Solh AA, Nopper J, Abdul-Khoudoud MR, et al. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients. Chest 1998, 114:138-145.
21. Kobashi Y, Yoshida K, Miyashita N, et al. Relationship between clinical efficacy of treatment of pulmonary My-cobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. J Infect Chemother 2006, 12:195-202.
22. Kobashi Y, Matsushima T The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan-including a follow-up study. Respiration 2007, 74:394-400.